<DOC>
	<DOCNO>NCT02555501</DOCNO>
	<brief_summary>The aim study evaluate therapeutic action diameter lesion , low level laser ( LLL ) associate photodynamic therapy ( PDT ) oral mucositis ( OM ) lesion , young patient . A randomized clinical trial blind , split-mouth performed . The study sample consist 15 cancer patient ( 3-16 year old ) Aldenora Bello Hospital ( São Luís , Maranhão , Brazil ) . Random allocation lot treatment ( PDT + LLL LLL ) quadrants oral cavity perform , patient control . Patients mask therapy perform side arch . The evaluation period therapeutic regimen 8 day , outcome assess lesion size ( measure cm² ) . Friedman Wilcoxon test apply effect magnitude calculate . The significance level 5 % . Statistically significant difference observe group lesion diameter 6th 8th day ( great regression lesion size PDT + LLL group ) , confirm difference magnitude moderate . Based finding , conclude PDT + LLL show great therapeutic effect compare LLL reduce severity OM lesion .</brief_summary>
	<brief_title>Oral Mucositis Laser Therapy Associated With Photodynamic Therapy</brief_title>
	<detailed_description>The blind randomize clinical trial include 18 young patient , 3 16 year old , undergoing chemotherapy chemo/radiological pediatric ward Aldenora Bello Hospital São Luís ( Maranhão , Brazil ) . The study conduct October/2014 January/2015 . It adopt inclusion criterion patient 3 18 year old , inductive phase chemotherapy , oral mucositis ( OM ) bilateral lesion . A mouth split model conduct , patient control . The entry patient study occur consecutively . To patient , operator/examiner draft envelope contain treatment either side , mask patient treatment side : PDT ( photosensitize low level laser ) + low level laser ; Low level laser ] . The following parameter use calculation sample size : 95 % confidence level , 80 % statistical power minimal difference 0.82 point lesion diameter detect paired sample . A `` n '' sample minimum 14 determined treatment . In order compensate possible loss , 18 patient treat . The treatment ( PDT low level laser ; Low level laser ) perform hospital bed . Prior treatment , OM lesion evaluate lesion side chosen . Lesions locate site side . The chosen site lip mucosa . Before procedure , patient instruct brush use mouthwash , follow clean oral cavity gauze distil water . Two day laser treatment , side oral cavity choose experimental treatment ( PDT low level laser ) pigment photosensitizer ( aqueous solution 0.005 % methylene blue ) . A ball sterile cotton soak dye solution place center lesion . Photosensitizer remain place 5 minute ( pre-irradiation period ) . Then , activate dye , lesion irradiate red light ( InGaAlP / phosphide Indium , Gallium potassium ) ( Flash Laser III , DMC , São Carlos , São Paulo , Brazil ) , wavelength 660 nm , period 90 second , power 100mW , 1cm away , accord manufacturer 's specification . The lesion opposite side treat ball sterile cotton soak distilled water laser unit place lesion without activation light . This procedure aim mask patient side receive experimental therapy ( PDT low level laser ) . This mask possible experimental solution insipid , soluble thus leave residue . From 3rd 10th day ( total 8 day ) carry laser therapy side . Lesions evaluate 8th day . After 8th day assessment , lesion treat complete remission well lesion present oral cavity . For laser therapy first use infrared emitter laser unit active medium AsGaAl ( Gallium Arsenide Aluminium ) , wavelength 808nm , analgesia . Then , investigator use red emitter , whose active medium InGaAlP ( phosphide Indium , Gallium Potassium ) , wavelength 660nm photobiomodulation . For unit emit laser , tip device close edge lesion , perpendicular tissue . A irradiation continuous application punctual ( 10 second ) . The distance point irradiation 1cm . The energy deliver 4J per point application . The interval session 24 hour . The tip laser disinfect 70 % alcohol solution wrap plastic film . Patients operator wear glass eye protection . A questionnaire contain demographic , socioeconomic type treatment cancer apply parent child . White blood cell count platelet ( begin end inductive phase QT ) extract medical record . The assessed outcome measure diameter lesion ( cm2 ) . The area lesion measure flexible ruler ( record make cm2 ) operator/examiner start treatment exclusive laser therapy ( 3rd day ) . This procedure repeat subsequent day 8th day laser treatment . The measurement lesion occur prior laser therapy application . The Friedman test use multiple comparison within group ( different time treatment ) . Paired evaluation two moment evaluate use Wilcoxon test , significance correct Bonferroni test ( p = 0.0071 ) . The Wilcoxon test use compare diameter lesion , every day , PDT + Low level laser Low level laser group ( dependent samples/split-mouth ) . It calculate effect magnitude ( ) standardize difference average two group . The level significance analysis 5 % .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<mesh_term>Photosensitizing Agents</mesh_term>
	<criteria>Patients 3 18 year old Patients chemotherapy inductive phase Patients oral mucositis bilateral lesion Patients outside establish age Patients phase chemotherapy Patients bilateral lesion</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>child</keyword>
	<keyword>cancer</keyword>
	<keyword>stomatitis</keyword>
	<keyword>clinical trial</keyword>
	<keyword>laser therapy , low-level</keyword>
	<keyword>methylene blue</keyword>
	<keyword>photochemotherapy</keyword>
</DOC>